# 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy

Source: https://onco.cc/trials/nct05479136/  
OnCo record `nct05479136` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Fluciclovine F-18 in Glioma & glioblastoma, run by Nicole Hill, with a status the registry has not verified recently.

## Summary

18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy is a phase 3 interventional study registered as NCT05479136 by Nicole Hill, with 30 participants planned, started 2022-08-24 and due to reach its primary completion in 2023-12-31. Interventions recorded: PET imaging with 18F fluciclovine. Conditions recorded: Grade III or Grade IV Glioma.

Linked to the drug Fluciclovine F-18 because the registry names it among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05479136
- Phase: 3
- Setting: 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy
- Sponsor: Nicole Hill
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT05479136: https://clinicaltrials.gov/study/NCT05479136

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- drugs: [Fluciclovine F-18](https://onco.cc/drugs/fluciclovine-f18/)

---
JSON: https://onco.cc/api/v1/entities/nct05479136.json